Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Bellevue Group AG Stock Portfolio

$6.56Billion– No. of Holdings #169

Bellevue Group AG Performance:
2024 Q1: 3.39%YTD: 3.39%2023: 1.06%

Performance for 2024 Q1 is 3.39%, and YTD is 3.39%, and 2023 is 1.06%.

About Bellevue Group AG and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Bellevue Group AG reported an equity portfolio of $6.6 Billions as of 31 Mar, 2024.

The top stock holdings of Bellevue Group AG are IONS, ARGX, NBIX. The fund has invested 5.5% of it's portfolio in IONIS PHARMACEUTICALS INC and 4.9% of portfolio in ARGENX SE.

The fund managers got completely rid off AXONICS INC (AXNX), COOPER COS INC (COO) and ZAI LAB LTD (ZLAB) stocks. They significantly reduced their stock positions in LABORATORY CORP AMER HLDGS (LH), JOHNSON & JOHNSON (JNJ) and VIKING THERAPEUTICS INC (VKTX). Bellevue Group AG opened new stock positions in COOPER COS INC (COO), STERIS PLC (STE) and ANNEXON INC (ANNX). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, SI-BONE INC (SIBN) and ABBVIE INC (ABBV).
Bellevue Group AG Equity Portfolio Value
Last Reported on: 15 May, 2024

Bellevue Group AG Annual Return Estimates Vs S&P 500

Our best estimate is that Bellevue Group AG made a return of 3.39% in the last quarter. In trailing 12 months, it's portfolio return was 7.71%.

New Buys

Ticker$ Bought
cooper cos inc40,317,500
steris plc16,509,400
annexon inc15,647,000
neogenomics inc14,871,500
glaukos corp5,273,260
teva pharmaceutical inds ltd2,006,620
bristol-myers squibb co1,270,930
4d molecular therapeutics in500,202

New stocks bought by Bellevue Group AG

Additions

Ticker% Inc.
structure therapeutics inc2,858
si-bone inc810
abbvie inc310
tenet healthcare corp193
spdr s&p 500 etf tr156
recursion pharmaceuticals in143
esperion therapeutics inc ne136
mckesson corp85.39

Additions to existing portfolio by Bellevue Group AG

Reductions

Ticker% Reduced
laboratory corp amer hldgs-97.91
johnson & johnson-77.3
viking therapeutics inc-69.14
outset med inc-67.48
rhythm pharmaceuticals inc-61.97
bridgebio pharma inc-61.56
merus n v-56.83
astrazeneca plc-55.04

Bellevue Group AG reduced stake in above stock

Sold off

Ticker$ Sold
axonics inc-114,078,000
kosmos energy ltd-1,721,120
zai lab ltd-3,714,330
cooper cos inc-32,559,800
ww intl inc-350,000
life time group holdings inc-380,016
inhibrx inc-934,800
supernus pharmaceuticals inc-436,994

Bellevue Group AG got rid off the above stocks

Sector Distribution

Bellevue Group AG has about 89.7% of it's holdings in Healthcare sector.

Sector%
Healthcare89.7
Others10.2

Market Cap. Distribution

Bellevue Group AG has about 50.6% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP47.6
MID-CAP28
UNALLOCATED9.7
SMALL-CAP8.5
MICRO-CAP3.2
MEGA-CAP3

Stocks belong to which Index?

About 0% of the stocks held by Bellevue Group AG either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others100
Top 5 Winners (%)%
VKTX
viking therapeutics inc
170.5 %
GBIO
generation bio co
142.4 %
FATE
fate therapeutics inc
96.2 %
NVDA
nvidia corporation
81.7 %
BDTX
black diamond therapeutics i
80.4 %
Top 5 Winners ($)$
MGNX
macrogenics inc
50.8 M
ISRG
intuitive surgical inc
49.3 M
BSX
boston scientific corp
33.8 M
AGIO
agios pharmaceuticals inc
27.9 M
SYK
stryker corporation
27.1 M
Top 5 Losers (%)%
PACB
pacific biosciences calif in
-54.2 %
OM
outset med inc
-47.4 %
MTEM
molecular templates inc
-40.0 %
TXG
10x genomics inc
-32.2 %
NVRO
nevro corp
-30.2 %
Top 5 Losers ($)$
IONS
ionis pharmaceuticals inc
-62.2 M
PACB
pacific biosciences calif in
-38.9 M
ALNY
alnylam pharmaceuticals inc
-37.4 M
RLAY
relay therapeutics inc
-16.1 M
SAGE
sage therapeutics inc
-13.5 M

Bellevue Group AG Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Bellevue Group AG

Bellevue Group AG has 169 stocks in it's portfolio. About 37.2% of the portfolio is in top 10 stocks. IONS proved to be the most loss making stock for the portfolio. MGNX was the most profitable stock for Bellevue Group AG last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions